Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Y Warren

Showing results (71-80 of 132) with videos related to

Pageof 14
Sort By:
Oncogene|January 17, 2025
Evidence of DNA methylation heterogeneity and epipolymorphism in kidney cancer tissue samplesSabrina H Rossi, Victoria Dombrowe, Laura Godfrey, et al.
BJU International|March 28, 2026
Long-term outcomes of cribriform-positive and cribriform-negative prostate cancer treated with radical prostatectomy in the ProtecT trialNikita Sushentsev, Anne Y Warren, Richard Colling, et al.
Science Advances|September 28, 2022
Accurate detection of benign and malignant renal tumor subtypes with MethylBoostER: An epigenetic marker-driven learning frameworkSabrina H Rossi, Izzy Newsham, Sara Pita, et al.
Cancers|February 26, 2025
K-Means Clustering of Hyperpolarised <sup>13</sup>C-MRI Identifies Intratumoral Perfusion/Metabolism Mismatch in Renal Cell Carcinoma as the Best Predictor of the Highest GradeInes Horvat-Menih, Alixander S Khan, Mary A McLean, et al.
Endocrine-Related Cancer|January 7, 2015
HES5 silencing is an early and recurrent change in prostate tumourigenesisCharles E Massie, Inmaculada Spiteri, Helen Ross-Adams, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 2025
Spatial metabolomics informs the use of clinical imaging for improved detection of cribriform prostate cancerNikita Sushentsev, Gregory Hamm, Roido Manavaki, et al.
BMC Cancer|May 27, 2020
Independence of HIF1a and androgen signaling pathways in prostate cancerMaxine G B Tran, Becky A S Bibby, Lingjian Yang, et al.
Nature Genetics|March 8, 2016
Gene regulatory mechanisms underpinning prostate cancer susceptibilityThomas Whitington, Ping Gao, Wei Song, et al.
Cell Reports|December 22, 2021
Resolving the immune landscape of human prostate at a single-cell level in health and cancerZewen Kelvin Tuong, Kevin W Loudon, Brendan Berry, et al.
European Radiology Experimental|July 9, 2024
High-resolution and highly accelerated MRI T2 mapping as a tool to characterise renal tumour subtypes and gradesInes Horvat-Menih, Hao Li, Andrew N Priest, et al.
Pageof 14

Showing results (71-80 of 132) with videos related to

Sort By:
Pageof 14
Oncogene|January 17, 2025
Evidence of DNA methylation heterogeneity and epipolymorphism in kidney cancer tissue samplesSabrina H Rossi, Victoria Dombrowe, Laura Godfrey, et al.
BJU International|March 28, 2026
Long-term outcomes of cribriform-positive and cribriform-negative prostate cancer treated with radical prostatectomy in the ProtecT trialNikita Sushentsev, Anne Y Warren, Richard Colling, et al.
Science Advances|September 28, 2022
Accurate detection of benign and malignant renal tumor subtypes with MethylBoostER: An epigenetic marker-driven learning frameworkSabrina H Rossi, Izzy Newsham, Sara Pita, et al.
Cancers|February 26, 2025
K-Means Clustering of Hyperpolarised <sup>13</sup>C-MRI Identifies Intratumoral Perfusion/Metabolism Mismatch in Renal Cell Carcinoma as the Best Predictor of the Highest GradeInes Horvat-Menih, Alixander S Khan, Mary A McLean, et al.
Endocrine-Related Cancer|January 7, 2015
HES5 silencing is an early and recurrent change in prostate tumourigenesisCharles E Massie, Inmaculada Spiteri, Helen Ross-Adams, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 2025
Spatial metabolomics informs the use of clinical imaging for improved detection of cribriform prostate cancerNikita Sushentsev, Gregory Hamm, Roido Manavaki, et al.
BMC Cancer|May 27, 2020
Independence of HIF1a and androgen signaling pathways in prostate cancerMaxine G B Tran, Becky A S Bibby, Lingjian Yang, et al.
Nature Genetics|March 8, 2016
Gene regulatory mechanisms underpinning prostate cancer susceptibilityThomas Whitington, Ping Gao, Wei Song, et al.
Cell Reports|December 22, 2021
Resolving the immune landscape of human prostate at a single-cell level in health and cancerZewen Kelvin Tuong, Kevin W Loudon, Brendan Berry, et al.
European Radiology Experimental|July 9, 2024
High-resolution and highly accelerated MRI T2 mapping as a tool to characterise renal tumour subtypes and gradesInes Horvat-Menih, Hao Li, Andrew N Priest, et al.
Pageof 14